Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy

Radiotherapy and Oncology

Volumn 88, Issue 1, 2008, Pages 46-52

  Pieters, Bradley R ^a   van de Kamer, Jeroen B ^a   van Herten, Yvonne R J ^a   van Wieringen, Niek ^a   D'Olieslager, Greet M ^a   van der Heide, Uulke A ^b   Koning, Caro C E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Biologically effective dose; Brachytherapy; Dose volume histograms; EQD2; Intensity modulated radiotherapy; Prostate neoplasms

Indexed keywords

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

ANALYSIS OF VARIANCE; BRACHYTHERAPY; DOSE FRACTIONATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RELATIVE BIOLOGICAL EFFECTIVENESS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 45849132052     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.02.023     Document Type: Article

References (33)

1. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8 (1982) 1981-1997
2. Berndt A., Rickey D.W., Rathee S., and Bews J. Size and positioning reproducibility of an 192Ir brachytherapy stepping source. Med Phys 27 (2000) 129-131
3. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
4. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low a/b ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6-13
5. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
6. Dale R.G. The application of the linear-quadratic dose-effect equation to the fractionated and protracted radiotherapy. Br J Radiol 58 (1985) 515-528
7. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
8. Demanes D.J., Rodriguez R.R., Schour L., Brandt D., and Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61 (2005) 1306-1316
9. Fowler J., Chapell R., and Ritter M. Is a/b for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
10. Fowler J.F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncologica 44 (2005) 265-276
11. Galalae R.M., Kovács G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
12. Hoskin P.J. High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer. Radiother Oncol 57 (2000) 285-288
13. Hoskin P.J., Motohashi K., Bownes P., Bryant L., and Ostler P. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiother Oncol 84 (2007) 114-120
14. Kal H.B., and van Gellekom M.P.R. How low is the a/b ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 57 (2003) 1116-1121
15. King C.R., DiPetrillo T.A., and Wazer D.E. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models. Int J Radiat Oncol Biol Phys 46 (2000) 165-172
16. Kotte A.N.T.J., Hofman P., Lagendijk J.J.W., van Vulpen M., and van der Heide U.A. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 69 (2007) 419-425
17. Kupelian P.A., Thakkar V.V., Khuntia D., et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 63 (2005) 1463-1468
18. Lukka H., Hayter C., Julian J.A., et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 23 (2005) 6132-6138
19. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. Int J Radiat Oncol Biol Phys 49 (2001) 61-69
20. Nahum A.E., Movsas B., Horwitz E.M., Stobbe C.C., and Chapman J.D. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the a/b ratio. Int J Radiat Oncol Biol Phys 57 (2003) 391-401
21. Nederveen A.J., van der Heide U.A., Hofman P., Welleweerd H., and Lagendijk J.J.W. Partial boosting of prostate tumours. Radiother Oncol 61 (2001) 117-126
22. Nickers P., Thissen B., Jansen N., and Deneufbourg J.M. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. Radiother Oncol 78 (2006) 47-52
23. Pieters B.R., van der Grient J.N.B., Blank L.E.C.M., et al. Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. Radiother Oncol 80 (2006) 69-72
24. Pollack A., Hanlon A.L., Horwitz E.M., et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 64 (2006) 518-526
25. Thames. An "incomplete-repair" model for survival after fractionated and continuous irradiations. Int J Radiat Biol 47 (1985) 319-339
26. Valdagni R., Italia C., Montanaro P., et al. Is the alpha-beta ratio for prostate cancer really low? A prospective, non randomized trial comparing standard and hypofractionated conformal radiation therapy. Radiother Oncol 75 (2005) 74-82
27. van't Riet A., Mak A.C.A., Moerland M.A., Elders L.H., and van der Zee W. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 37 (1997) 731-736
28. van der Kogel A.J. Radiation response and tolerance of normal tissues. In: Steel G.G. (Ed). Basic clinical radiobiology (2002), Arnold, London 30-41
29. Vargas C.E., Martinez A.A., Boike T.P., et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study. Int J Radiat Oncol Biol Phys 66 (2006) 416-423
30. Wang J.Z., Guerrero M., and Allen Li X. How low is the a/b ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 55 (2003) 194-203
31. Wang J.Z., and Allen Li X. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys 30 (2003) 34-40
32. Williams S.G., Taylor J.M.G., Liu N., et al. Use of individual fraction size data from 3756 patients to directly determine the a/b ratio of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 24-33
33. Zelefsky M.J., Chan H., Hunt M., et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176 (2006) 1415-1419